Long-term results of stem cell transplantation for MS: A single-center experience

Neurology

Volumn 76, Issue 12, 2011, Pages 1066-1070

  Fassas, A ^a   Kimiskidis, V K ^b   Sakellari, I ^a   Kapinas, K ^b   Anagnostopoulos, A ^a   Tsimourtou, V ^b   Sotirakoglou, K ^b   Kazis, A ^b  

^a Bone Marrow Transplantation and Gene and Cell Therapy Unit   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMAGE ENHANCEMENT; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 79953208669     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318211c537     Document Type: Article

References (10)

1. Fassas A, Anagnostopoulos A, Kazis A, et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant 1997;20:631-638. (Pubitemid 27477575)
2. Fassas A, Nash R. Multiple sclerosis. Best Pract Res Clin Haematol 2004;17:247-262. (Pubitemid 39145097)
3. Lechner-Scott J, Kappos L, Hofman M, et al. Can the Expanded Disability Status Scale be assessed by telephone? Mult Scler 2003;9:154-159. (Pubitemid 36426990)
4. Kimiskidis V, Sakellari I, Tsimourtou V, et al. Treatment of a malignant form of multiple sclerosis with immune ablation and autologous stem cell transplantation. Mult Scler 2008;14:278-283. (Pubitemid 351639644)
5. Mancardi GL, Murialdo A, Rossi P, et al. Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. Mult Scler 2005;11:367-371. (Pubitemid 40775198)
6. Portaccio E, Amato MP, Siracusa G, et al. Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases. Mult Scler 2007;13:676-678. (Pubitemid 46939538)
7. Fagius J, Lundgren J, Oberg G. Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation. Mult Scler 2009;15:229-237.
8. Muraro PA, Douek DC, Packer A, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005;201:805-816. (Pubitemid 40395124)
9. Daumer M, Griffith LM, Meister W, et al. Survival, and time to an advanced disease state or progression, of untreated patients with moderately severe multiple sclerosis in a multicenter observational database: relevance for design of a clinical trial for high dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation. Mult Scler 2006;12:174-179.
10. Saccardi R, Kozak T, Bocelli-Tyndall C, et al. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group of Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler 2006;12:814-823. (Pubitemid 46111776)